Seqens Seqens

X

List of Certificates of Suitability (CEPs) for 07741_FLUKA Active Pharmaceutical Ingredient issued by the EDQM and listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-072 - Rev 01
Valid
Chemical
2023-04-19
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2022-143 - Rev 00
Valid
Chemical
2022-08-31
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2022-235 - Rev 00
Valid
Chemical
2022-08-26
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2019-323 - Rev 00
Valid
Chemical
2022-01-31
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
CEP 2022-367 - Rev 00
Valid
Chemical
2024-02-15
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-192 - Rev 02
Valid
Chemical
2024-02-22
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-367 - Rev 01
Valid
Chemical
2023-05-16
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag South Korea
Digital Content Digital Content
URL Supplier Web Content
CEP 2019-321 - Rev 01
Valid
Chemical
2023-11-30
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
CEP 2022-106 - Rev 00
Valid
Chemical
2024-01-11
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Spain
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2019-256 - Rev 02
Valid
Chemical
2023-04-27
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Netherlands
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-260 - Rev 01
Valid
Chemical
2024-02-23
2918
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 159351-69-6 / Everolimus API manufacturers, exporters & distributors?

Everolimus manufacturers, exporters & distributors 1

19

PharmaCompass offers a list of Everolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Everolimus manufacturer or Everolimus supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Everolimus manufacturer or Everolimus supplier.

PharmaCompass also assists you with knowing the Everolimus API Price utilized in the formulation of products. Everolimus API Price is not always fixed or binding as the Everolimus Price is obtained through a variety of data sources. The Everolimus Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Everolimus

Synonyms

001, rad, 40-o-(2-hydroxyethyl)-rapamycin, 40-o-(2-hydroxyethyl)rapamycin, Afinitor, Certican, Rad

Cas Number

159351-69-6

Unique Ingredient Identifier (UNII)

9HW64Q8G6G

About Everolimus

A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.

07741_FLUKA Manufacturers

A 07741_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 07741_FLUKA, including repackagers and relabelers. The FDA regulates 07741_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 07741_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 07741_FLUKA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

07741_FLUKA Suppliers

A 07741_FLUKA supplier is an individual or a company that provides 07741_FLUKA active pharmaceutical ingredient (API) or 07741_FLUKA finished formulations upon request. The 07741_FLUKA suppliers may include 07741_FLUKA API manufacturers, exporters, distributors and traders.

click here to find a list of 07741_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

07741_FLUKA CEP

A 07741_FLUKA CEP of the European Pharmacopoeia monograph is often referred to as a 07741_FLUKA Certificate of Suitability (COS). The purpose of a 07741_FLUKA CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 07741_FLUKA EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 07741_FLUKA to their clients by showing that a 07741_FLUKA CEP has been issued for it. The manufacturer submits a 07741_FLUKA CEP (COS) as part of the market authorization procedure, and it takes on the role of a 07741_FLUKA CEP holder for the record. Additionally, the data presented in the 07741_FLUKA CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 07741_FLUKA DMF.

A 07741_FLUKA CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 07741_FLUKA CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of 07741_FLUKA suppliers with CEP (COS) on PharmaCompass.

07741_FLUKA Manufacturers | Traders | Suppliers

07741_FLUKA Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY